| Literature DB >> 26634741 |
Juergen Fink1, Amanda Andersson-Rolf1, Bon-Kyoung Koo1.
Abstract
Lineage tracing is a widely used method for understanding cellular dynamics in multicellular organisms during processes such as development, adult tissue maintenance, injury repair and tumorigenesis. Advances in tracing or tracking methods, from light microscopy-based live cell tracking to fluorescent label-tracing with two-photon microscopy, together with emerging tissue clearing strategies and intravital imaging approaches have enabled scientists to decipher adult stem and progenitor cell properties in various tissues and in a wide variety of biological processes. Although technical advances have enabled time-controlled genetic labeling and simultaneous live imaging, a number of obstacles still need to be overcome. In this review, we aim to provide an in-depth description of the traditional use of lineage tracing as well as current strategies and upcoming new methods of labeling and imaging.Entities:
Mesh:
Year: 2015 PMID: 26634741 PMCID: PMC4791321 DOI: 10.5483/bmbrep.2015.48.12.249
Source DB: PubMed Journal: BMB Rep ISSN: 1976-6696 Impact factor: 4.778
Fig. 1.C. elegans early development and BrdU tracing. (A) Schematic representation of C. elegans embryonic development. The germline develops from one single primordial germ cell (PGC) which appears in the early embryo at the 4-cell stage. This PGC will divide and give rise to the two PGCs Z2 and Z3. These PGCs will not divide further until after hatching. Postembryonic divisions result in variable, non-reproducible placement of the daughter cells (3, 4). (B) Illustration of bromodeoxyuridine (BrdU), a synthetic nucleoside that is analogous to thymidine, and how it is incorporated into the genome. (C) Representation of how BrdU is diluted during tracing. Rapid self-renewal of the stem cells (top row) will lead to dilution of BrdU. In contrast, quiescent stem cells (bottom row) will retain the BrdU label. During asymmetric self-renewal the progenitor cells divide and give rise to differentiated cells, leading to a dilution of BrdU.
Fig. 2.Examples of different reporter lines. (A) LacZ reporter system in which Cre-mediated excision of the STOP cassette results in lacZ expression, which can later be visualized by X-gal staining. The expression of Cre recombinase is driven by a cell-type or tissue specific (TS) promoter. Tamoxifen administration induces recombination and subsequent LacZ expression in CreERT2 expressing cells. The genetic label is inherited by all daughter cells allowing tracing of the progeny of individual labelled cells. (B) Multi-color reporter. In this system the administration of tamoxifen leads to random recombination of four fluorescent proteins (GFP, YFP, CFP and RFP). Subsequently, the cells expressing CreERT2 under a tissue specific (TS) promoter will also randomly express one of the four colors. The genetic label is inherited by all daughter cells allowing tracing of the progeny of individual labelled cells in one of four colors. (C) eGFP-IRES-CreERT2 cassette. Expression of GFP by a cell-type or tissue specific (TS) promoter mediates green fluorescent labeling of the cell type of interest. The bicistronic eGFP-IRES-CreERT2 construct allows for inducible recombination in the GFP labelled cell population. Combined with a fluorescent reporter, this results in the expression of a second fluorescent protein under a ubiquitous promoter (here Rosa-YFP). In a stem cell that goes through asymmetric division, the daughter cell that remains a stem cell will express both colors (from the ubiquitous and cell-type specific promoter) while the daughter cell that differentiates and thereby turns off the cell-type specific promoter will only be labeled in one color (driven by the ubiquitous promoter).
Fig. 3.Lineage tracing of Lgr5+ intestinal stem cells using the lacZ reporter system. Lineage tracing of Lgr5+ stem cells. An eGFP-coupled, tamoxifen inducible knock-in mouse is used in which the expression of eGFP and CreERT2 is driven by the LGR5 promoter. All Lgr5+ stem cells express eGFP. Following the administration of tamoxifen, recombined stem cells express Lgr5 promoter driven eGFP and ubiquitous promoter driven LacZ. Upon division, daughter cells of Lgr5+ stem cells either remain as stem cells expressing both GFP and lacZ, or differentiate turning off the expression of Lgr5 expressing only the lacZ reporter gene. LacZ+ cells derived from labelled Lgr5+ stem cells quickly move upwards towards the villi (day 5). Neutral drift within the stem cell zone results in complete labeling of the entire crypt within several weeks. All cells of the adjacent villi have been replaced by labelled progeny of one initially labelled Lgr5+ stem cell (day 60).
Fluorescence Microscopy for Lineage Tracing Imaging
| Standard Fluorescence Microscope | Laser scanning Confocal Microscope | 2-photon Confocal Microscope | Light Sheet Microscope | |
|---|---|---|---|---|
|
| ||||
| Imaging depth | All (Out of focus because of lacking focal plane selection) | Up to 500 μm | Up to 1 mm | Up to 500 μm |
| Image plane selection | No | Yes | Yes | Yes |
| Photo bleaching | Medium – High (LED light for reduced bleaching | Medium | Low | Very Low (Due to increased imaging speed and selected illumination) |
| Cell Viability | Low – High (LED light for increased cell viability) | High | High | Very High (Due to increased imaging speed and selected illumination) |
| Excitation | All | Entire specimen in objective focal axis | Limited to objective focal volume | Entire specimen in focal plane |
| Laser light scattering | N/A | High | Low | Very high |
| Emission light scattering | N/A | Dependent on specimen and image depth | Dependent on specimen and image depth | Dependent on specimen, mounting, and image depth |
| Price | Low - High | High | Very High (Laser) | Low - Very High |
| Main Limitations | Imaging Depth, Z-resolution | Imaging time, photo-damage | Imaging time, heat, price | Imaging depth (Steric hindrance), price, specimen mounting is crucial, implementation of most recent optimizations ongoing |
| Main advantages | Accessibility, very good for 2D of thin sections, additional deconvolution | Accessibility, 3D imaging | Imaging depth, low photodamage | Imaging speed, very low photodamage, specimen size |
Tissue clearing summary
| BABB | Scale | Tetrahydrofuran (THF) (Ertürk | 3DISCO | CLARITY | PACT (passive CLARITY technique ) / PARS (perfusion-assisted agent release in situ) | |
|---|---|---|---|---|---|---|
|
| ||||||
| Fixation method and other tissue preparation | PFA perfusion | PFA perfusion | PFA perfusion | PFA perfusion | PFA, acrylamide, bis-acrylamide, VA044 perfusion | PFA perfusion and subsequent hydrogel / initiator perfusion |
| Dehydration | Yes | No | Yes | Yes | No | No |
| Clearing solution | Benzylalcohol, benzylbenzoate | ScaleA2: Urea, glycerol, Triton X-100 | THF, dichloromethane (DCM), benzylalcohol, benzylbenzoate | THF, DCM, dibenzyl ether (DBE) | Active transport organ-electrophoresis approach -electrophoretic tissue clearing (ETC) in sodium borate buffer containing 4% SDS | Up to 2 weeks 8%SDS in PBS, pH 7.5 at 37°-42℃ followed by extensive PBS perfusion washing over 2-3 days |
| Time of protocol | Up to 3 days or more | 3 days - several weeks (- months) | ∼1 day | ∼1 day | ∼7-21 days | 2-3 days for most organs, 1-2 weeks for whole brain |
| Tissue clearing principle (RI matching) | Dehydration | Increased RI of aqueous phase | Dehydration and lipid removal (THF) | Dehydration and lipid removal (DCM) | Ionic lipid extraction (Passive or electrophoretic) | Ionic lipid extraction |
| Fluorescence quenching | High (Dehydration) | Minimal | High (Dehydration) | Continuous quenching in final clearing solution | No | No |
| Main Disadvantages | Not compatible with tissues containing a high degree of lipids, fluorescence quenching, autofluorescence, benzylbenzoate and benzylalcohol are toxic and dissolve plastic | Long clearing process, fragility of cleared samples, sample expansion | Impaired ultrastructure, loss of cellular and molecular information due to lipid removal, benzylbenzoate and benzylalcohol are toxic and dissolve plastic | Quenching in final clearing solution requires immediate imaging, loss of cellular and molecular information due to lipid removal | Passive: Long clearing Electrophoretic: Additional equipment needed (platinum electrodes), possible epitope loss, heating | Relatively slow for large organs like whole brain (compared to BABB, Scale, THF or 3DISCO), perfusion chamber required |
| Main Advantages | Accessibility to reagents | Signal preservation of fluorescent proteins, adjustable formula for various organs, low toxicity of chemicals | Reduced fluorescence quenching, antibody use possible, but long incubation times required | Relatively low fluorescence quenching, lipid removal, antibody use possible, but long incubation times required | Preservation of biological information by providing physical framework, no quenching due to ionic extraction technique, deep antibody penetration with long incubation times | Superior to CLARITY due to lack of electrophoresis and reduction of tissue degradation, more cost effective than CLARITY, reduced tissue swelling, fast simultaneous clearing of multiple tissues |
Fig. 4.Intravital imaging of the intestinal stem cell niche. Intravital images of the same intestinal crypt after tamoxifen mediated labelling of Lgr5-CreERT2 expressing stem cells on a confetti reporter background. The panels illustrate how two clones (red and blue) expand on dispense of a yellow clone, which gets pushed out of the stem cell zone.
Fig. 5.Overview of available strategies. Lineage tracing experimental design workflow highlighting specific aspects to take into consideration when following a subset or all of the proposed strategies.